Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to... see more

TSXV:SBM - Post Discussion

Sirona Biochem Corp > LACK OF TRUST AND INVESTOR CONFIDENCE
View:
Post by bealert on Sep 25, 2024 2:52pm

LACK OF TRUST AND INVESTOR CONFIDENCE

It's evident by only trading about 50 thousand shares so far today that most investors are reluctant to yet believe management, in spite of the press release sounding very positive.

In the good ole days, when we had more belief, this would have risen maybe 10 cents by now, but.................we all know the sound of hollow howhee and that again is evident by the lack lustre trading today.

If we were more sure, there would be many folks loading up now and driving the price.

I'm not trying to sound negative here, just reiterating the past, with hope that we can overcome the agony of bygone days and finally have a REAL COMPANY here, with real and believable information.

Let's hope there are a lot of desperate or vain folks out there that want to get rid of their dark spots and imperfections of the skin.

Like I said before, Sirona needs to use their own creme to wipe out their own DARK spots of jerking us around for years.

All the best to our investors over the next few months.  After all, we will all look forward to a "MERRY CHRISTMAS", with our stockings filled with 'spotless' hope for a good future for SIRONA.

BeAlert
Comment by MirrorWorldMan on Sep 25, 2024 3:43pm
Howie said that the GlycoP launch in 2025 could possibly bring profitability, not the AbbVie deal.  Suggesting there is not alot of money expected from SkinMedica.  Barely a paragraph of a footnote on a key inline revenue generator 1067.  My guess is Howie is distracting shareholders with the GlycoP pumping to distract from no 1067 launch date or monies.  And yes, consistent ...more  
Comment by forhandlaren on Sep 26, 2024 12:51am
I'm not defending Howard, but what you suggest is simply not true. Yes, Howard has stated that the Abbvie deal revenue should make the company profitable. The management claims they are prohibited to give away any information about Abbvie product launch. The NR states that the company should be profitable during 2025 due to anti-aging launch. This does not imply that the Abbvie product won ...more  
Comment by bazooka73 on Sep 26, 2024 1:46am
I have to agree with MWM. On the occasion of the AbbVie deal, Howie already ‘promised’ that Sirona would become profitable. Since then, exactly nothing has happened. On the contrary, they are obviously struggling with challenges in the search for money (no wonder). Now the next announcement that Sirona is to become profitable. And how many times have we heard that they are in talks with God knows ...more  
Comment by Pandora on Sep 27, 2024 12:37am
Sirona Biochem Announces Exclusive Global Licensing Agreement with Allergan Aesthetics GlobeNewswire June 13, 2022 So it has been 27 months since the Allergen deal was announced. What is the total revenue received from that deal in that time? Presumably management income was not affected by that income? Now we are talking about our 2nd big contract coming due possibly in the first ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities